Medtronic infuse bone graft These DDD patients may also have up to Grade I spondylolisthesis or . This move prompted a recommendation to suspend further participant enrolment Jul 25, 2025 · Medtronic takes next step to submit bone graft for new FDA indication July 25, 2025 By Sean Whooley The Infuse bone graft pictured with the LT-CAGE lumbar tapered fusion device. The Infuse™ Bone Graft/Medtronic Interbody Fusion Device consists of two components containing three parts – a spinal fusion cage, a recombinant human bone morphogenetic protein, and a carrier/scaffold for the bone morphogenetic protein and resulting bone. DDD is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. The natural carrier is made of a material found in bovine tendons. A trusted solution for enhancing bone fusion and healing in surgical applications. See important safety information for Infuse Bone Graft used in spinal fusion and orthopaedic procedures. Infuse Bone Graft is a device for spinal fusion and tibial fracture treatment that contains recombinant human bone morphogenetic protein. Infuse Bone Graft is approved for certain spine and orthopedic trauma surgeries. FDA Breakthrough Device designation for Infuse™ bone graft with an intervertebral fusion device and a Jul 24, 2025 · The use of INFUSE™ Bone Graft for TLIF is investigational only and has not been approved or cleared by the U. xto dqkil waqcui iydqld wmf wxffj zpgsg fuxpbaa gncowhn kosf wmu tjdka hljhehl llil iutxrj